KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Inovio Pharmaceuticals (INO) Income from Non-Controlling Interests (2019 - 2020)

Inovio Pharmaceuticals' Income from Non-Controlling Interests history spans 8 years, with the latest figure at -$469407.0 for Q2 2020.

  • For Q2 2020, Income from Non-Controlling Interests fell 144.67% year-over-year to -$469407.0; the TTM value through Mar 2021 reached -$469407.0, up 72.67%, while the annual FY2020 figure was -$1.1 million, 10.8% up from the prior year.
  • Income from Non-Controlling Interests for Q2 2020 was -$469407.0 at Inovio Pharmaceuticals, up from -$594350.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at -$69605.0 in Q1 2019 and bottomed at -$594350.0 in Q1 2020.